• Australia

Australian Pharma Stocks Analysis

ASX:ZLD
ASX:ZLD
ASX:ZLDPharmaceuticals

Is Zelira Therapeutics (ASX:ZLD) In A Good Position To Invest In Growth?

July 14, 2022
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
ASX:CU6
ASX:CU6
ASX:CU6Pharmaceuticals

Individual investors invested in Clarity Pharmaceuticals Ltd (ASX:CU6) up 15% last week, insiders too were rewarded

July 13, 2022
A look at the shareholders of Clarity Pharmaceuticals Ltd ( ASX:CU6 ) can tell us which group is most powerful. And the...
ASX:AGH
ASX:AGH
ASX:AGHPharmaceuticals

We Think Althea Group Holdings (ASX:AGH) Needs To Drive Business Growth Carefully

July 11, 2022
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
ASX:MVP
ASX:MVP
ASX:MVPPharmaceuticals

Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

July 04, 2022
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
ASX:MXC
ASX:MXC
ASX:MXCPharmaceuticals

MGC Pharmaceuticals (ASX:MXC) Has Debt But No Earnings; Should You Worry?

June 23, 2022
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
ASX:RCE
ASX:RCE
ASX:RCEPharmaceuticals

Individual investors who hold 52% of Recce Pharmaceuticals Ltd (ASX:RCE) gained 39%, insiders profited as well

June 22, 2022
If you want to know who really controls Recce Pharmaceuticals Ltd ( ASX:RCE ), then you'll have to look at the makeup...
ASX:CAU
ASX:CAU
ASX:CAUPharmaceuticals

While shareholders of Cronos Australia (ASX:CAU) are in the black over 1 year, those who bought a week ago aren't so fortunate

June 20, 2022
It might be of some concern to shareholders to see the Cronos Australia Limited ( ASX:CAU ) share price down 19% in the...
ASX:WFL
ASX:WFL
ASX:WFLPharmaceuticals

Insiders who purchased Wellfully Limited (ASX:WFL) earlier this year lose an additional AU$80k as the stock sinks to AU$0.049

June 15, 2022
Insiders who bought AU$231k worth of Wellfully Limited's ( ASX:WFL ) stock at an average buy price of AU$0.075 over the...
ASX:MYX
ASX:MYX
ASX:MYXPharmaceuticals

Insiders who bought in the last 12 months lose an additional AU$32k as Mayne Pharma Group Limited (ASX:MYX) drops to AU$450m

June 14, 2022
The recent 12% drop in Mayne Pharma Group Limited's ( ASX:MYX ) stock could come as a blow to insiders who purchased...
Last
  • 1
  • 2
  • 3
  • 4
  • 5
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.